H D Bear - JoVE Visualize

Showing results (21-30 of 58) with videos related to

Pageof 6

Sort By:

Cellular Immunology|March 1, 1991

Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithineB M Susskind, J Sekar, P M Tandon, et al.

Journal of Neuro-Oncology|March 1, 1997

Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytesC D Rice, N G Baldwin, R T Biron, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992

Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophoreT M Tuttle, T H Inge, C M McCrady, et al.

Annals of Surgical Oncology|January 1, 1994

Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppressionT M Tuttle, M D Fleming, P S Hogg, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Cyclophosphamide and abrogation of tumor-induced suppressor T cell activityS K Hoover, S K Barrett, T M Turk, et al.

Breast Cancer Research and Treatment|August 10, 2000

Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institutionS Latosinsky, D Cornell, H D Bear, et al.

International Journal of Immunopharmacology|September 16, 2000

Protective role of IL-2 during activation of T cells with bryostatin 1F J Kos, D L Cornell, A B Lipke, et al.

Cancer Research|March 15, 1992

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1T H Inge, S K Hoover, B M Susskind, et al.

The Journal of Surgical Research|June 9, 2001

Bryostatin/ionomycin-activated T cells mediate regression of established tumorsC S Chin, L J Graham, G G Hamad, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992

Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytesT H Inge, K M McCoy, B M Susskind, et al.

Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:

Pageof 6

Cellular Immunology|March 1, 1991

Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithineB M Susskind, J Sekar, P M Tandon, et al.

Journal of Neuro-Oncology|March 1, 1997

Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytesC D Rice, N G Baldwin, R T Biron, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992

Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophoreT M Tuttle, T H Inge, C M McCrady, et al.

Annals of Surgical Oncology|January 1, 1994

Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppressionT M Tuttle, M D Fleming, P S Hogg, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Cyclophosphamide and abrogation of tumor-induced suppressor T cell activityS K Hoover, S K Barrett, T M Turk, et al.

Breast Cancer Research and Treatment|August 10, 2000

Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institutionS Latosinsky, D Cornell, H D Bear, et al.

International Journal of Immunopharmacology|September 16, 2000

Protective role of IL-2 during activation of T cells with bryostatin 1F J Kos, D L Cornell, A B Lipke, et al.

Cancer Research|March 15, 1992

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1T H Inge, S K Hoover, B M Susskind, et al.

The Journal of Surgical Research|June 9, 2001

Bryostatin/ionomycin-activated T cells mediate regression of established tumorsC S Chin, L J Graham, G G Hamad, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992

Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytesT H Inge, K M McCoy, B M Susskind, et al.

Pageof 6